DAILY CLEANSER

Product NDC: 58876-101
11-digit product format: 588760101
Labeler code: 58876
Product ID: 58876-101_25a6216f-6a84-49d8-bd6b-bb2601bd99b0
Type: HUMAN OTC DRUG
Nonproprietary name: SALICYLIC ACID
Dosage form: GEL
Route: TOPICAL
Labeler: DR LIN SKINCARE
Application: part333D
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2013-06-13
Marketing end: 0000-00-00
Substance: SALICYLIC ACID
Active strength: 2 g/100mL
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	58876-101		I	Inactivated by FDA	2026-10-15
excluded package	package	58876-101	58876-101-14	I	Inactivated by FDA	2026-10-15
excluded package	package	58876-101	58876-101-18	I	Inactivated by FDA	2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 66 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58876-101-18	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58876-101-14	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58876-101-18	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58876-101-14	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58876-101-18	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58876-101-14	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58876-101-18	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58876-101-14	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58876-101-18	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58876-101-14	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58876-101-18	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58876-101-14	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	58876-101-18	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	58876-101-14	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	58876-101-18	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	58876-101-14	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	58876-101-18	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	58876-101-14	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	58876-101-18	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	58876-101-14	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	58876-101-18	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	58876-101-14	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	58876-101-18	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	58876-101-14	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	58876-101-18	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	58876-101-14	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	58876-101-18	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	58876-101-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	58876-101-18	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	58876-101-14	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	58876-101-18	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	58876-101-14	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	58876-101-18	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	58876-101-14	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	58876-101-18	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	58876-101-14	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	58876-101-18	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	58876-101-14	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	58876-101-18	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	58876-101-14	`e2bbac7714bc…`	`27bdfed8d636…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c5cd4727-ac49-4409-82b1-5bd8006c3ec7	Product name	1	20171122

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
58876-101-14	2019-11-27	C162847	48780-1	9855d018-def5-cd31-e053-dbdaa90ab51a	99b45eef-216f-40fc-9b86-68597a6804fd
58876-101-18	2019-11-27	C162847	48780-1	9855d018-def5-cd31-e053-dbdaa90ab51a	99b45eef-216f-40fc-9b86-68597a6804fd

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
58876-101-14	DAILY CLEANSERSALICYLIC ACID ACNE TREATMENT	120 mL in 1 BOTTLE	GEL	120		2
58876-101-18	DAILY CLEANSERSALICYLIC ACID ACNE TREATMENT	240 mL in 1 BOTTLE	GEL	240		2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
ALLANTOIN	INACTIVE INGREDIENT	344S277G0Z	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
AMINOMETHYLPROPANOL	INACTIVE INGREDIENT	LU49E6626Q	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
ARBUTIN	INACTIVE INGREDIENT	C5INA23HXF	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
ASCORBIC ACID	INACTIVE INGREDIENT	PQ6CK8PD0R	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
KOJIC ACID	INACTIVE INGREDIENT	6K23F1TT52	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
LAURYL GLUCOSIDE	INACTIVE INGREDIENT	76LN7P7UCU	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
METHYLISOTHIAZOLINONE	INACTIVE INGREDIENT	229D0E1QFA	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
PANTHENOL	INACTIVE INGREDIENT	WV9CM0O67Z	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
PEG-150 DISTEARATE	INACTIVE INGREDIENT	6F36Q0I0AC	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
SODIUM COCOAMPHOACETATE	INACTIVE INGREDIENT	W7Q5E87674	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
SODIUM COCOYL GLUTAMATE	INACTIVE INGREDIENT	BMT4RCZ3HG	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
SODIUM LAURETH SULFATE	INACTIVE INGREDIENT	BPV390UAP0	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
SODIUM LAURYL GLYCOL CARBOXYLATE	INACTIVE INGREDIENT	8L0472VMYL	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
SODIUM PYRROLIDONE CARBOXYLATE	INACTIVE INGREDIENT	469OTG57A2	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
58876-101	DAILY CLEANSER SALICYLIC ACID ACNE TREATMENT (SALICYLIC ACID) GEL [DR LIN SKINCARE]	2	Legacy NDC, 2 package rows	20130618_99b45eef-216f-40fc-9b86-68597a6804fd.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
O414PZ4LPZ	SALICYLIC ACID	69-72-7	SALICYLIC ACID

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
562600	salicylic acid 2 % Medicated Liquid Soap	PSN	99b45eef-216f-40fc-9b86-68597a6804fd	2
562600	salicylic acid 20 MG/ML Medicated Liquid Soap	SCD	99b45eef-216f-40fc-9b86-68597a6804fd	2
562600	salicylic acid 2 % Facial Cleanser Toner	SY	99b45eef-216f-40fc-9b86-68597a6804fd	2
562600	salicylic acid 2 % Facial Scrub	SY	99b45eef-216f-40fc-9b86-68597a6804fd	2
562600	salicylic acid 2 % Medicated Liquid Soap	SY	99b45eef-216f-40fc-9b86-68597a6804fd	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
58876-101-14	58876010114	120 mL in 1 BOTTLE	120 ml	Historical
58876-101-18	58876010118	240 mL in 1 BOTTLE	240 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
SALICYLIC ACID - DR LIN SKINCARE \| Westwood Laboratories Inc.	DR LIN SKINCARE \| Westwood Laboratories Inc.	2013-06-17	HUMAN OTC DRUG LABEL	2